Allmed Solutions Ltd

Tel Aviv Stock Exchange ALMD.TA

Allmed Solutions Ltd Return on Assets (ROA) for the year ending December 31, 2023: 2.40%

Allmed Solutions Ltd Return on Assets (ROA) is 2.40% for the year ending December 31, 2023, a 112.40% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Allmed Solutions Ltd Return on Assets (ROA) for the year ending December 31, 2022 was -19.37%.
Allmed Solutions Ltd Return on Assets (ROA) for the year ending December 31, 2020 was -19.33%.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Tel Aviv Stock Exchange: ALMD.TA

Allmed Solutions Ltd

CEO	Prof. Oz Shapira
IPO Date	Dec. 24, 2007
Location	Israel
Headquarters	2 Ha'Eshel Street
Employees	19
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Drugstores & Retail Pharmacies Glass Personal Care Pharmaceuticals Plastics

Description

Allium Medical Solutions Ltd. develops, manufactures, and sells long-term, fully covered, expandable, and retrievable stents for the treatment of the various obstructions in the urinary and GI tract in Israel and internationally. The company offers ureteric, bulbar, triangular and round prostatic, and biliary stents. Allium Medical Solutions Ltd. is based in Caesarea, Israel.

Key trends

Past 5 years